Reply to Santhanam Sundar and Paul Symonds' Letter to the Editor re: Syed A. Hussain, Nuria Porta, Emma Hall, et al. Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial. Eur Urol 2021;79:307-15.
作者信息
Hussain Syed A, Porta Nuria, Hall Emma, Qureshi Muneeb, Lewis Rebecca, Huddart Robert, James Nicholas D
机构信息
Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Institute of Cancer Research, Royal Marsden Hospital, London, UK.
出版信息
Eur Urol. 2021 Aug;80(2):e51-e52. doi: 10.1016/j.eururo.2021.05.009. Epub 2021 May 28.
PMID:34053780
Abstract
摘要
相似文献
1
Reply to Santhanam Sundar and Paul Symonds' Letter to the Editor re: Syed A. Hussain, Nuria Porta, Emma Hall, et al. Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial. Eur Urol 2021;79:307-15.回复桑塔纳姆·桑达尔和保罗·西蒙兹致编辑的信，信的内容是关于赛义德·A·侯赛因、努丽娅·波尔塔、艾玛·霍尔等人的《BC2001试验中接受新辅助化疗后行（化疗）放疗的肌层浸润性膀胱癌患者的结局》。《欧洲泌尿外科杂志》2021年；79卷：307 - 315页。
Eur Urol. 2021 Aug;80(2):e51-e52. doi: 10.1016/j.eururo.2021.05.009. Epub 2021 May 28.
2
Re: Syed A. Hussain, Nuria Porta, Emma Hall, et al. Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial. Eur Urol 2021;79:307-15.回复：赛义德·A·侯赛因、努丽娅·波尔塔、艾玛·霍尔等。BC2001试验中接受新辅助化疗后再行（化疗）放疗的肌肉浸润性膀胱癌患者的治疗结果。《欧洲泌尿外科杂志》2021年；79卷：307 - 315页。
Eur Urol. 2021 Aug;80(2):e49-e50. doi: 10.1016/j.eururo.2021.05.007. Epub 2021 May 21.
3
Re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer?回复：白云锦、杨玉波和唐寅致编辑的信，主题为：安德里亚·内奇、马尔科·班迪尼、朱塞平娜·卡莱雷索等人。多参数磁共振成像作为肌肉浸润性膀胱癌新辅助派姆单抗治疗肿瘤反应的无创评估：PURE - 01研究的初步结果。《欧洲泌尿外科杂志》2020年；77卷：636 - 43页。《欧洲泌尿外科杂志》2020年；77卷：e158：多参数磁共振成像能否取代传统的经尿道膀胱癌切除术？
Eur Urol. 2021 Jan;79(1):e35-e36. doi: 10.1016/j.eururo.2020.08.006. Epub 2020 Aug 20.
6
Reply to Yunjin Bai, Yubo Yang, Yin Tang's Letter to the Editor, re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01, Study. Eur Urol 2020;77:636-43.回复白云锦、杨玉波、唐寅致编辑的信，主题：安德里亚·内奇、马尔科·班迪尼、朱塞平娜·卡莱雷索等人。多参数磁共振成像作为肌肉浸润性膀胱癌新辅助派姆单抗治疗肿瘤反应的无创评估：PURE - 01研究的初步结果。《欧洲泌尿外科杂志》2020年；77卷：636 - 43页
Eur Urol. 2020 Jun;77(6):e159-e160. doi: 10.1016/j.eururo.2020.03.009. Epub 2020 Mar 14.
7
Reply to Wei Liu, Xiaoping Liu, Sheng Li's Letter to the Editor, re: Robert A. Huddart, Emma Hall, Rebecca Lewis, et al. Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial. Eur Urol 2020;77:260-8.回复刘薇、刘晓平、李盛致编辑的信，主题：罗伯特·A·哈达特、艾玛·霍尔、丽贝卡·刘易斯等人。BC2001三期随机对照试验中接受放疗±化疗的肌层浸润性膀胱癌患者的患者报告生活质量结果。《欧洲泌尿外科杂志》2020年；77卷：260 - 268页
Eur Urol. 2020 Jun;77(6):e156-e157. doi: 10.1016/j.eururo.2020.02.013. Epub 2020 Mar 10.
8
Re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43.回复：安德里亚·内奇、马尔科·班迪尼、朱塞平娜·卡莱雷索等。多参数磁共振成像作为肌肉浸润性膀胱癌新辅助派姆单抗治疗肿瘤反应的无创评估：PURE - 01研究的初步结果。《欧洲泌尿外科杂志》2020年；77卷：636 - 43页。
Eur Urol. 2020 Jun;77(6):e158. doi: 10.1016/j.eururo.2020.03.008. Epub 2020 Mar 19.
9
Re: Robert A. Huddart, Emma Hall, Rebecca Lewis, et al. Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial. Eur Urol 2020;77:260-8.
Eur Urol. 2020 Jun;77(6):e154-e155. doi: 10.1016/j.eururo.2020.02.014. Epub 2020 Feb 26.
10
Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7. Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?对乔普·J·德容和伊万·A·吉布致编辑的信的回复，信的主题为：戈特弗里德·舍达尔、约翰·亚伯拉罕松、卡琳·霍尔姆斯特伦等人。尿路上皮癌分子亚型对新辅助化疗的不同反应。《欧洲泌尿外科杂志》。2022年；81卷：316 - 7页。肌层浸润性膀胱癌的新辅助化疗反应：内在生物学差异还是亚型命名差异？
Eur Urol. 2022 Apr;81(4):e92-e93. doi: 10.1016/j.eururo.2021.12.035. Epub 2022 Jan 14.
Zotero 插件